Speaker: Massimo Bongiovanni, MD, Synlab Pathology, Lausanne, Switzerland
In 2017 the second edition of The Bethesda System for Reporting Thyroid Cytopathology (TBSRTC) was released. The new version incorporated the re-classification done by the WHO of some thyroid papillary carcinomas into the NIFTP (noninvasive follicular thyroid neoplasm with papillary-like nuclear features), that has implications for the risk of malignancy and for the diagnostic criteria. Moreover, new management options concerning molecular test were introduced for some diagnostic categories.
This webinar will concentrate in the new updates (as in the second edition) of TBSRTC concerning the diagnostic categories and when and how apply molecular test to cytological specimens. Different possibilities available on the marker will be analyzed and compared with test that can be performed in house.
Credits: Outro Sound Effect: [ Ссылка ] (Stock Music Free Licence)
